Print this page    •   Back to Web version of article

U.S. News
Vertex Hepatitis C Drug Incivek Gets "Black Box" Warning Over Possible Fatal Skin Condition

December 20, 2012

The Food and Drug Administration (FDA) is requiring a black box warning on the Vertex Pharmaceuticals hepatitis C medication Incivek due to a potentially fatal skin rash. The FDA says that patients taking Incivek in combination with the medications ribavirin and interferon, which is taken by injection, should stop taking it immediately if they develop a rash that becomes worse or develops in tandem with other symptoms, such as fever, diarrhea, or mouth sores. The black box warning is the most serious form of safety warning available for medications.

Back to other news for December 2012

Excerpted from:
Washington Post
12.19.2012; Associated Press




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/70139/vertex-hepatitis-c-drug-incivek-gets-black-box-war.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.